{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T16:05:39Z","timestamp":1794758739437,"version":"4.9.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pre-diabetes is a growing health concern where a large percentage of these patients develop full type 2 diabetes. Effective interventions on pre-diabetes can prevent or delay the occurrence or development of diabetes. Pharmaco-dynamics and pre-clinical of JinQi-Jiangtang tablets (JQJT) suggest that it could be benefit for pre-diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/Design<\/jats:title>\n            <jats:p>Randomized controlled trial (RCT) is implemented in this study. The study term is 24 months (12 months for intervention and 12 months for follow up). Participants are recruited from four cities of China: Beijing, Tianjin, Xi'an and Nanning. Four hundred participants are randomized to treatment group (JQJT tablets) and control group (Placebo); two hundred participants each. People being included in this study must have been diagnosed as pre-diabetes via western medicine criteria and traditional Chinese medicine (TCM) criteria. The end-point indexes include: incidence of diabetes mellitus and reversion rate. Primary outcome indexes include: oral glucose tolerance test; insulin releasing test; glycosylated hemoglobin (HA1c). Secondary outcome indexes include: score of the Short Form 36 Health Survey Questionnaire (SF-36); score of TCM symptoms; blood lipid test. Indexes of safety include: general medical examination; blood and urine regular test; electrocardiogram (ECG), liver function (ALT) and renal function (BUN, Creatinine) test; record of adverse event, such as headache, faint, etc. Qualitative control will be implemented and a number of standard operating processes (SOPs) will be formed throughout the study: laboratory quality control measures; compliance control for researchers and participants; researcher training before study; supervision; investigational drug management and others.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The aim of this study is to evaluate the effectiveness and safety of JinQi JiangTang (JQJT) tablets for the treatment of patients with pre-diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Chinese clinical trials register ChiCTR-TRC-00000401<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1745-6215-11-27","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T07:14:53Z","timestamp":1268205293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Hongbo","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcai","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiantao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"438_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/(SICI)1096-9136(199607)13:7<663::AID-DIA130>3.0.CO;2-G","volume":"13","author":"CY Pan","year":"1996","unstructured":"Pan CY, Lu JM, Tian H, Kong XT, Lu XP, Yao C, Jiang CE, Deng XX, Wang SY, Zhang XL, Wang ZS, Cui L: Study of the prevalence of diabetes mellitus in adults in the shougang corporation in Beijing. Diabetes Med. 1996, 13: 663-68. 10.1002\/(SICI)1096-9136(199607)13:7<663::AID-DIA130>3.0.CO;2-G.","journal-title":"Diabetes Med"},{"key":"438_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2169\/internalmedicine.34.108","volume":"34","author":"Pan Xiao Ren","year":"1995","unstructured":"Pan Xiao Ren , LI Guang Wei , Hu Ying Hua : Diet and exercise intervention in the treatment of diabetes incidence rate of 530 cases of impaired glucose tolerance 6 years prospective observation of the crowd. Chinese Journal of internal medicine. 1995, 34: 108-111.","journal-title":"Chinese Journal of internal medicine"},{"key":"438_CR3","first-page":"7","volume":"11","author":"Xiaoyan Xing","year":"2003","unstructured":"Xing Xiaoyan: The life style intervention treats IGT the feasibility and the curative effect and the appraisal. Liaoning practical diabetes magazine. 2003, 11: 7-8.","journal-title":"Liaoning practical diabetes magazine"},{"key":"438_CR4","first-page":"340","volume":"12","author":"JM Lu","year":"2004","unstructured":"Lu JM: Abnormal glucose metabolism with metabolic syndrome risk investigation and analysis - discussion suited to the Chinese population with metabolic syndrome diagnostic criteria. Chinese Journal of Diabetes. 2004, 12: 340-343.","journal-title":"Chinese Journal of Diabetes"},{"key":"438_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jama.290.4.486","volume":"290","author":"JL Chiasson","year":"2003","unstructured":"Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trial Research Group: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003, 290: 486-94. 10.1001\/jama.290.4.486.","journal-title":"JAMA"},{"key":"438_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Diabetes prevention program research group reduction in the incidence of type 2 diabetes with lifestyle intervention metformin. N Engl J Med. 2002, 346: 393-403. 10.1056\/NEJMoa012512.","journal-title":"N Engl J Med"},{"key":"438_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0197-2456(97)00151-7","volume":"19","author":"SP Azen","year":"1998","unstructured":"Azen SP, Peters RK, Berkowitz K, Kjos S, Xiang A, Buchanan TA: TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Controlled Clinical Trials. 1998, 19: 217-31. 10.1016\/S0197-2456(97)00151-7.","journal-title":"Controlled Clinical Trials"},{"key":"438_CR8","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","volume":"368","author":"The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) trial investigators","year":"2006","unstructured":"The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) trial investigators: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet. 2006, 368: 1096-105. 10.1016\/S0140-6736(06)69420-8.","journal-title":"Lancet"},{"key":"438_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJMoa065061","volume":"355","author":"The DREAM trial investigators","year":"2006","unstructured":"The DREAM trial investigators: Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006, 355: 1551-62. 10.1056\/NEJMoa065061.","journal-title":"N Engl J Med"},{"key":"438_CR10","first-page":"150","volume":"24","author":"KL Chan","year":"2004","unstructured":"Chan KL: On the treatment of diabetes in Chinese medicine research and development. Foreign Medical endocrinology fascicle. 2004, 24: 150-","journal-title":"Foreign Medical endocrinology fascicle"},{"key":"438_CR11","volume-title":"Beijing Chinese medicine university masters graduation thesis","author":"KL Yan","year":"2007","unstructured":"Yan KL: Astronavigation, and so on. Beijing Chinese medicine university masters graduation thesis. 2007"},{"key":"438_CR12","first-page":"3","volume":"18","author":"ZN Zhou","year":"2002","unstructured":"Zhou ZN: Jinqi Jiangtang tablet on impaired glucose tolerance to explore the efficacy. Practical Journal of Investigational drug. 2002, 18: 3-4.","journal-title":"Practical Journal of Investigational drug"},{"issue":"2","key":"438_CR13","first-page":"24","volume":"7","author":"ZF Shen","year":"1996","unstructured":"Shen ZF, Xie MZ, Liu HF: Influence of JinQI-jiangtang tablet on animals of glycometabolism. Traditional Chinese Drug Research & Clinical Pharmacology. 1996, 7 (2): 24-26.","journal-title":"Traditional Chinese Drug Research & Clinical Pharmacology"},{"key":"438_CR14","unstructured":"Mechanism of Chinese goldthread on reduction of blood sugar. Shandong Journal of Traditional Chinese Medicine. 2005, 11: 688-"},{"key":"438_CR15","first-page":"17","volume":"11","author":"LL Ji","year":"1999","unstructured":"Ji LL: The herbalism analysis of berberine on diabetes. J Sichuan Tradit Med. 1999, 11: 17-19.","journal-title":"J Sichuan Tradit Med"},{"key":"438_CR16","first-page":"23","volume":"1","author":"MZ Xie","year":"1997","unstructured":"Xie MZ, Liu HF: Influence of JiQi-Jiangtang on blood fat, insulin resistance, immune function of animals. Traditional Chinese Drug Research & Clinical Pharmacology. 1997, 1: 23-24.","journal-title":"Traditional Chinese Drug Research & Clinical Pharmacology"},{"key":"438_CR17","first-page":"215","volume":"24","author":"ZF Shen","year":"2004","unstructured":"Shen ZF: Pharmacological base of JinQi-Jiangtang tablet on diabetes. Foreign Medical Sciences Section of Endocrine. 2004, 24: 215-216.","journal-title":"Foreign Medical Sciences Section of Endocrine"},{"key":"438_CR18","first-page":"87","volume":"1","author":"WY Gu","year":"2004","unstructured":"Gu WY: Clinical evaluation of efficacy of Jinqi hypoglycemic tablet with Gliclazide in the treatment of type 2 diabetes mellitus. Journal of Tianjin Medical University. 2004, 1: 87-89.","journal-title":"Journal of Tianjin Medical University"},{"key":"438_CR19","first-page":"301","volume":"33","author":"RR Zhang","year":"2005","unstructured":"Zhang RR, Liu Y: The influence of JinQi-Jiangtang tablet on excretion rate of microalbumin of IGT patients. Tianjing Medical Journal. 2005, 33: 301-30.","journal-title":"Tianjing Medical Journal"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-11-27\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-11-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:23:10Z","timestamp":1630473790000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-11-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["438"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-11-27","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]},"assertion":[{"value":"15 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}